Global Pharmatech Statistics
Total Valuation
GBLP has a market cap or net worth of 83.54 million.
| Market Cap | 83.54M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
GBLP has 415.21 million shares outstanding.
| Current Share Class | 415.21M |
| Shares Outstanding | 415.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.27 |
| PB Ratio | 9.10 |
| P/TBV Ratio | 10.62 |
| P/FCF Ratio | 1,890.83 |
| P/OCF Ratio | 488.98 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.86 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | 59.40 |
| Interest Coverage | -9.83 |
Financial Efficiency
Return on equity (ROE) is -22.59% and return on invested capital (ROIC) is -11.45%.
| Return on Equity (ROE) | -22.59% |
| Return on Assets (ROA) | -10.39% |
| Return on Invested Capital (ROIC) | -11.45% |
| Return on Capital Employed (ROCE) | -25.12% |
| Revenue Per Employee | 14,652 |
| Profits Per Employee | -10,323 |
| Employee Count | 217 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 1.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.13% in the last 52 weeks. The beta is -0.32, so GBLP's price volatility has been lower than the market average.
| Beta (5Y) | -0.32 |
| 52-Week Price Change | +34.13% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 25.72 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, GBLP had revenue of 3.18 million and -2.24 million in losses. Loss per share was -0.10.
| Revenue | 3.18M |
| Gross Profit | 1.47M |
| Operating Income | -2.31M |
| Pretax Income | -2.28M |
| Net Income | -2.24M |
| EBITDA | -1.81M |
| EBIT | -2.31M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 5.44 million in cash and 2.62 million in debt, giving a net cash position of 2.81 million or 0.01 per share.
| Cash & Cash Equivalents | 5.44M |
| Total Debt | 2.62M |
| Net Cash | 2.81M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 9.18M |
| Book Value Per Share | 0.34 |
| Working Capital | 3.76M |
Cash Flow
In the last 12 months, operating cash flow was 170,847 and capital expenditures -126,665, giving a free cash flow of 44,182.
| Operating Cash Flow | 170,847 |
| Capital Expenditures | -126,665 |
| Free Cash Flow | 44,182 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 46.24%, with operating and profit margins of -72.55% and -70.45%.
| Gross Margin | 46.24% |
| Operating Margin | -72.55% |
| Pretax Margin | -71.73% |
| Profit Margin | -70.45% |
| EBITDA Margin | -57.03% |
| EBIT Margin | -72.55% |
| FCF Margin | 1.39% |
Dividends & Yields
GBLP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.68% |
| FCF Yield | 0.05% |
Stock Splits
The last stock split was on February 3, 2005. It was a reverse split with a ratio of 0.1.
| Last Split Date | Feb 3, 2005 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
GBLP has an Altman Z-Score of 1.26. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | n/a |